Total Payments
$3,374
2024 Payments
$779.00
Companies
20
Transactions
187
Medicare Patients
4,594
Medicare Billing
$414,256
Payment Breakdown by Category
Food & Beverage$3,345 (99.1%)
Education$28.79 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,345 | 185 | 99.1% |
| Education | $28.79 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,163 | 70 | $0 (2024) |
| Lilly USA, LLC | $386.30 | 18 | $0 (2024) |
| Allergan, Inc. | $290.93 | 17 | $0 (2020) |
| GlaxoSmithKline, LLC. | $247.65 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $224.67 | 13 | $0 (2024) |
| Amgen Inc. | $192.57 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $118.81 | 5 | $0 (2019) |
| Astellas Pharma US Inc | $115.45 | 7 | $0 (2024) |
| Novo Nordisk Inc | $113.88 | 5 | $0 (2024) |
| PFIZER INC. | $108.33 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $779.00 | 37 | ABBVIE INC. ($200.75) |
| 2023 | $624.85 | 30 | Lilly USA, LLC ($142.40) |
| 2022 | $427.57 | 25 | ABBVIE INC. ($254.38) |
| 2021 | $200.58 | 18 | AbbVie Inc. ($200.58) |
| 2020 | $169.02 | 16 | Allergan, Inc. ($154.15) |
| 2019 | $362.12 | 14 | Allergan Inc. ($136.78) |
| 2018 | $355.37 | 21 | AbbVie, Inc. ($131.47) |
| 2017 | $455.14 | 26 | AbbVie, Inc. ($122.28) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: PAIN | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.98 | General |
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: Obesity | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: PAIN | ||||||
| 08/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Obesity | ||||||
| 08/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.20 | General |
| 04/09/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,016 | 1,496 | $289,234 | $101,932 |
| 2022 | 19 | 1,027 | 1,549 | $335,345 | $119,056 |
| 2021 | 19 | 1,208 | 1,705 | $190,848 | $94,428 |
| 2020 | 17 | 1,343 | 1,997 | $236,025 | $98,840 |
Total Patients
4,594
Total Services
6,747
Medicare Billing
$414,256
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 533 | $155,636 | $49,812 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 188 | 188 | $56,024 | $24,549 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 189 | $38,934 | $12,699 | 32.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 21 | 21 | $7,896 | $3,521 | 44.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 73 | 73 | $3,650 | $2,290 | 62.7% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 15 | 22 | $6,226 | $2,065 | 33.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 22 | $4,554 | $1,475 | 32.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 32 | $4,096 | $1,374 | 33.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 73 | 143 | $3,843 | $1,352 | 35.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 60 | 62 | $2,108 | $647.48 | 30.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $950.00 | $596.03 | 62.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 18 | 18 | $2,358 | $515.44 | 21.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 44 | $1,408 | $483.42 | 34.3% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 13 | $481.00 | $152.64 | 31.7% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 15 | 15 | $285.00 | $133.28 | 46.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 31 | 33 | $396.00 | $96.05 | 24.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 35 | 35 | $175.00 | $72.60 | 41.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 18 | 22 | $154.00 | $70.62 | 45.9% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 12 | 12 | $60.00 | $27.84 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 240 | 607 | $177,244 | $57,423 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 147 | 147 | $43,806 | $19,831 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 186 | 284 | $58,393 | $17,918 | 30.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 50 | 50 | $18,800 | $8,594 | 45.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 40 | 42 | $5,124 | $2,796 | 54.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 79 | 82 | $4,100 | $2,512 | 61.3% |
About Dr. Bartel Crisafi, MD
Dr. Bartel Crisafi, MD is a Family Medicine healthcare provider based in Westerly, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124079090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bartel Crisafi, MD has received a total of $3,374 in payments from pharmaceutical and medical device companies, with $779.00 received in 2024. These payments were reported across 187 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,345).
As a Medicare-enrolled provider, Crisafi has provided services to 4,594 Medicare beneficiaries, totaling 6,747 services with total Medicare billing of $414,256. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Westerly, RI
- Active Since 05/15/2006
- Last Updated 07/25/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124079090
Products in Payments
- VRAYLAR (Drug) $425.33
- UBRELVY (Drug) $406.15
- Creon (Drug) $253.75
- TRELEGY ELLIPTA (Drug) $202.07
- MOUNJARO (Drug) $182.10
- QULIPTA (Drug) $172.65
- JARDIANCE (Drug) $135.75
- Synthroid (Drug) $131.06
- FARXIGA (Drug) $103.73
- ENTRESTO (Drug) $99.35
- Wegovy (Drug) $92.27
- Prolia (Biological) $88.06
- EMGALITY (Drug) $71.32
- NURTEC ODT (Drug) $69.73
- MYRBETRIQ (Drug) $58.38
- TRULICITY (Drug) $54.65
- Cologuard Collection Kit (Device) $53.25
- INSPIRE (Device) $50.57
- Otezla (Drug) $45.95
- REXULTI (Drug) $41.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Westerly
Rocco Andreozzi, Do, DO
Family Medicine — Payments: $3,206
Family Medicine $3,206
Joseph Giancaspro, Md, MD
Family Medicine — Payments: $3,047
Family Medicine $3,047
Mr. Walter Curtice, M.d, M.D
Family Medicine — Payments: $1,762
Family Medicine $1,762
Ms. Marianne Longacre, Do, DO
Family Medicine — Payments: $367.41
Family Medicine $367.41
Peter Willis, M.d, M.D
Family Medicine
Family Medicine
Dr. Bernard Marzilli, Jr., D.o, D.O
Family Medicine
Family Medicine